The evolution of cell and gene therapy is reshaping drug discovery, providing new hope for rare diseases and cancer through innovative gene editing approaches.

Chemical process enhances room temperature stability - - Provisional patent applications filed -PURCHASE, N.Y., Feb. 20, 2025 (GLOBE ...

We are thrilled to have Patrick step into this pivotal role,” said Benedikt von Braunmühl, CEO of Rentschler Biopharma. “Patrick’s in-depth understanding of our clients’ needs, coupled with his ...

Nanoparticle characterization is vital for mRNA vaccine efficacy, ensuring safety and regulatory compliance in the ...

Abhijit Naravane, a partner at PA Consulting, outlines strategies to help biopharma operations leaders successfully navigate the complexities of a product launch.

We assign Siegfried a Medium Morningstar Uncertainty Rating. Its business is relatively stable, with high switching costs and good visibility due to long-term customer contracts. However, small ...

However, the shift of strategic direction to wellness has raised uncertainty over Kirin’s long-term growth prospects, where execution plays a key role in integrating the acquired subsidiary and ...

Agilent Technologies, Inc. (NYSE:A), a leading provider of analytical instruments and services for laboratories worldwide, ...